Gain Therapeutics GANX Growth Metrics (2020-2026)

NASDAQ GANX
$1.11 +0.03 (+2.78%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Gain Therapeutics Quarterly Growth Metrics

Periods 26 quarters
Latest Sep 2026

Gain Therapeutics reported asset growth of -2.09% for the quarter ended Sep 2026. These growth metrics cover 26 quarters of results from Jun 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Growth Ratios
Total Debt (QoQ)
-1.77%-6.74%-3.32%-6.51%3.09%-2.63%-1.57%-5.89%4.34%-10.60%-4.19%1.65%-11.31%-2.49%5.58%-6.01%-5.51%-6.84%-7.99%-10.18%
Total Debt Growth (5y)
-11.49%-12.36%-13.56%-15.27%
Total Debt Growth (3y)
-8.38%-11.10%-11.93%-11.23%-14.20%-12.92%-10.32%-10.16%-12.74%-14.01%-15.92%-17.22%
Total Debt Growth (1y)
-5.96%-10.38%-12.09%-17.19%-13.09%-9.27%-7.63%-7.02%-5.89%-13.59%-15.89%-9.15%-22.78%-15.77%-7.18%-14.17%-8.56%-12.64%-23.87%-27.25%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-31.29%77.88%-0.32%16.40%134.24%-38.39%-31.98%-65.69%678.74%-75.89%0.51%16.75%24.44%-11.88%-12.68%0.46%40.28%-33.64%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
38.99%29.52%24.20%8.41%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
92.82%19.81%97.82%12.54%27.75%11.02%19.55%8.96%-10.64%-24.68%-22.79%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
122.58%176.85%59.50%41.79%84.45%333.48%129.44%-66.32%11.96%-56.19%-35.26%120.30%-64.80%28.67%11.78%-3.81%8.43%-18.34%
Revenue (QoQ)
58.01%4.16%111.31%61.23%5.33%83.41%6.74%11.65%-34.38%-31.28%
Revenue Growth (5y)
43.36%46.20%63.43%55.59%77.58%-7.29%8.94%
Revenue Growth (3y)
102.22%-3.52%-23.51%-20.15%19.03%
Revenue Growth (1y)
372.79%754.17%6.65%460.73%22.61%130.25%43.45%-46.25%
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.95M0.01M0.19M0.23M0.19M-0.33M-2.95M-0.11M0.58M0.08M-0.04M-0.19M0.00M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.31M-0.36M0.61M1.23M4.11M-0.37M0.93M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.18M0.08M0.14M-2.26M-0.35M-0.65M-0.30M0.37M-0.01M0.32M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
1.03M3.95M-0.15M1.39M-0.22M-0.21M-0.77M0.51M0.43M-0.15M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
-704.00-560.000.00M0.00M-0.01M-0.01M0.00M0.00M0.00M632.000.00M-0.01M0.00M-222.000.02M0.00M0.00M0.00M
Return on Invested Capital [ROIC] Growth (5y)ROIC Growth (5y)
-0.01M-0.01M-0.01M
Return on Invested Capital [ROIC] Growth (3y)ROIC Growth (3y)
-0.02M-0.02M-0.02M-0.02M-0.02M-0.03M-0.03M0.00M0.00M0.01M
Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y)
0.00M0.00M0.00M-0.01M-0.01M-0.02M-0.01M0.00M0.00M0.00M-0.01M-0.01M-0.01M0.01M0.02M0.02M0.02M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-716.00-576.000.00M-976.00-0.01M-0.01M0.00M0.00M0.00M498.000.00M-0.01M-0.01M0.00M0.02M0.00M0.00M-878.00
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
-0.01M-0.01M-0.01M-0.01M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.02M-0.02M-0.02M-0.02M-0.02M-0.03M-0.03M-0.03M0.00M0.00M0.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M0.00M0.00M0.00M-0.01M-0.01M-0.02M-0.01M0.00M0.00M0.00M-0.01M-0.02M-0.02M0.01M0.02M0.02M0.02M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-588.00-681.00-906.000.00M-0.01M-0.01M0.00M0.00M0.00M0.00M0.00M-0.01M0.00M0.00M0.01M0.00M0.00M-672.00
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.01M-0.01M-0.01M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.02M-0.02M-0.01M-0.02M-0.03M-0.03M-0.02M0.00M0.00M0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.00M0.00M-0.01M-0.01M-0.02M-0.01M0.00M0.00M0.00M-0.01M-0.01M-0.01M0.01M0.02M0.02M0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-603.00-436.00-832.00-685.000.00M0.00M44.00874.00-48.0058.000.00M0.00M295.000.00M0.01M0.00M0.00M-780.00
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.01M-0.01M-0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M0.00M-419.000.00M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M0.00M-0.01M-0.01M0.00M0.00M928.000.00M0.00M0.00M-0.01M0.00M0.01M0.01M0.01M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
2.85%0.70%30.16%-1.58%5.60%0.18%-4.20%-8.06%-1.12%-11.16%10.74%-3.49%-13.37%-5.90%-1.35%-11.04%-12.45%-27.34%-13.61%-14.25%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
20.38%-0.10%-8.93%-17.11%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
61.99%26.93%18.19%5.09%-0.75%-2.97%-11.53%-14.46%-19.64%-27.80%-30.25%-31.85%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
257.66%95.05%85.06%32.67%36.22%35.52%-0.25%-6.82%-12.76%-22.63%-10.56%-6.11%-17.74%-12.87%-22.38%-28.46%-27.70%-44.17%-51.11%-52.88%
Operating Margin (QoQ)
0.95M0.01M0.19M0.23M-0.11M0.58M0.08M-0.04M-0.19M0.00M
Operating Margin Growth (5y)
-0.31M-0.36M0.61M1.23M4.11M-0.37M0.93M
Operating Margin Growth (3y)
-0.18M-0.35M-0.65M-0.30M0.37M
Operating Margin Growth (1y)
1.03M3.95M-0.15M1.39M-0.22M0.51M0.43M-0.15M
Operating Income (QoQ)Op. Inc (QoQ)
30.78%-2.48%-57.41%8.22%-47.83%36.81%9.78%0.67%-86.92%45.51%25.29%-31.17%-16.48%5.97%6.68%-19.87%12.55%31.58%
Operating Income Growth (5y)Op. Inc Growth (5y)
-53.53%-57.06%-42.34%-22.55%-16.76%-5.90%7.13%
Operating Income Growth (3y)Op. Inc Growth (3y)
-116.94%-143.96%-81.35%-39.73%-21.07%-32.54%1.29%-1.26%-9.94%0.56%-0.24%-0.78%15.40%13.12%
Operating Income Growth (1y)Op. Inc Growth (1y)
-98.61%-33.30%-47.28%-2.48%-59.03%-49.35%-2.82%16.29%-5.84%8.72%24.42%0.19%37.80%-7.33%-34.07%-22.52%8.01%33.07%
Net Margin (QoQ)
0.96M0.02M0.19M0.24M-0.24M0.69M0.13M-0.06M-0.16M0.01M
Net Margin Growth (5y)
-0.25M-0.51M0.51M1.27M4.05M-0.37M0.95M
Net Margin Growth (3y)
-0.06M-0.39M-0.83M-0.38M0.33M
Net Margin Growth (1y)
1.07M3.92M-0.14M1.41M-0.20M0.52M0.60M-0.08M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
30.96%-1.64%-55.39%10.37%-49.65%38.63%-0.12%15.02%-102.86%44.91%15.99%-20.22%-28.23%9.03%14.13%-23.61%16.64%32.41%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-50.63%-60.62%-46.08%-22.34%-18.01%-5.62%7.49%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-106.40%-141.87%-81.10%-41.83%-17.88%-31.80%1.29%-5.38%-11.45%-4.53%-5.05%-2.97%15.28%12.50%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-94.48%-33.55%-42.98%2.26%-56.98%-51.18%-3.51%21.86%-5.92%4.93%20.23%-12.85%28.66%-17.81%-20.42%-23.81%19.51%40.19%
Net Income (QoQ)
30.96%-1.64%-55.39%10.37%-49.65%38.63%-0.12%15.02%-102.86%44.91%15.99%-20.22%-28.23%9.03%14.13%-23.61%16.64%32.41%
Net Income Growth (5y)
-50.63%-60.62%-46.08%-22.34%-18.01%-5.62%7.49%
Net Income Growth (3y)
-106.40%-141.87%-81.10%-41.83%-17.88%-31.80%1.29%-5.38%-11.45%-4.53%-5.05%-2.97%15.28%12.50%
Net Income Growth (1y)
-94.48%-33.55%-42.98%2.26%-56.98%-51.18%-3.51%21.86%-5.92%4.93%20.23%-12.85%28.66%-17.81%-20.42%-23.81%19.51%40.19%
Net Cash Flow (QoQ)NCF (QoQ)
-87.34%40.17%116.24%-960.91%469.95%-110.13%980.30%-183.85%77.50%-20.18%-84.79%180.02%466.50%-136.23%23.35%60.96%
Net Cash Flow Growth (5y)NCF Growth (5y)
-33.52%-43.36%-24.85%54.38%-16.11%0.82%10.27%
Net Cash Flow Growth (3y)NCF Growth (3y)
-60.63%35.88%-30.39%81.65%-26.37%56.31%-33.29%34.24%17.02%-46.98%-157.07%12.08%
Net Cash Flow Growth (1y)NCF Growth (1y)
-136.35%-106.37%45.39%47.59%2,741.25%-176.73%-116.83%-99.60%-141.90%139.99%1,106.77%-203.50%-25.90%-161.42%
Income After Tax (QoQ)
30.96%-1.64%-55.39%10.37%-49.65%38.63%-0.12%15.02%-102.86%44.91%15.99%-20.23%-28.22%9.03%14.13%-23.61%16.64%32.41%
Income After Tax Growth (5y)
-50.63%-60.62%-46.08%-22.34%-18.01%-5.62%7.49%
Income After Tax Growth (3y)
-106.40%-141.87%-81.10%-41.83%-17.88%-31.80%1.29%-5.38%-11.45%-4.53%-5.05%-2.97%15.28%12.50%
Income After Tax Growth (1y)
-94.48%-33.55%-42.98%2.26%-56.98%-51.18%-3.51%21.86%-5.92%4.93%20.23%-12.86%28.66%-17.80%-20.42%-23.80%19.51%40.19%
Free Cash Flow (QoQ)FCF (QoQ)
-86.90%40.94%-18.84%21.05%-42.67%36.64%-60.50%-5.56%43.13%-10.59%-33.43%3.38%6.25%-2.36%1.01%34.89%
Free Cash Flow Growth (5y)FCF Growth (5y)
-38.21%-64.43%-45.46%-28.41%-10.74%-7.63%-6.50%
Free Cash Flow Growth (3y)FCF Growth (3y)
-77.38%-127.97%-73.74%-62.35%-8.11%-21.12%-39.79%5.98%-15.89%-3.79%2.34%8.42%
Free Cash Flow Growth (1y)FCF Growth (1y)
-214.30%13.50%-72.22%15.18%-14.56%-53.15%38.95%-6.55%11.42%18.92%-33.65%-23.71%8.22%38.15%
FCF Margin (QoQ)
-0.15M0.42M-0.25M0.57M0.08M0.05M-0.26M0.04M
FCF Margin Growth (5y)
0.19M-0.53M0.50M0.89M4.88M-0.40M0.09M
FCF Margin Growth (3y)
0.37M-0.40M0.26M
FCF Margin Growth (1y)
0.49M4.84M-0.22M0.44M0.43M-0.10M
EPS (Diluted) (QoQ)
19.33%13.06%-55.39%10.37%-44.19%40.15%2.26%38.50%-89.80%60.10%2.59%4.11%-21.23%21.14%8.85%3.50%17.90%33.78%
EPS (Diluted) Growth (5y)
6.93%9.44%25.93%23.39%18.30%28.73%
EPS (Diluted) Growth (3y)
-31.30%-14.43%16.22%23.73%-12.27%24.49%19.59%16.92%23.52%26.71%32.43%43.99%42.07%
EPS (Diluted) Growth (1y)
48.70%45.28%-42.90%2.31%-56.30%-45.03%3.16%48.13%31.72%54.49%54.64%29.27%54.82%10.69%16.43%15.90%43.05%52.18%
EPS (Basic) (QoQ)
19.33%13.06%-55.39%10.37%-44.19%40.15%2.26%38.50%-89.80%60.10%2.59%4.11%-21.23%21.14%8.85%3.50%17.90%33.78%
EPS (Basic) Growth (5y)
11.74%6.93%9.44%25.93%23.39%18.30%28.73%
EPS (Basic) Growth (3y)
-13.44%-31.30%-14.43%16.22%23.73%-12.27%24.49%19.59%16.92%23.52%26.71%32.43%43.99%42.07%
EPS (Basic) Growth (1y)
48.70%45.28%-42.90%2.31%-56.30%-45.03%3.16%48.13%31.72%54.49%54.64%29.27%54.82%10.69%16.43%15.90%43.05%52.18%
EBT (QoQ)
30.70%-1.33%-55.19%10.29%-49.62%38.70%-0.27%15.19%-103.84%45.04%27.07%-35.73%-27.96%16.46%5.65%-21.45%15.74%32.45%
EBT Margin (QoQ)
0.96M0.02M0.19M0.24M-0.24M0.73M0.07M-0.05M-0.17M0.01M
EBT Margin Growth (5y)
-0.22M-0.49M0.58M1.28M4.06M-0.35M0.97M
EBT Margin Growth (3y)
-0.05M-0.37M-0.80M-0.31M0.34M
EBT Margin Growth (1y)
1.07M3.92M-0.14M1.41M-0.20M0.51M0.58M-0.13M
EBT Growth (5y)
-50.02%-60.10%-42.94%-21.94%-17.26%-5.17%7.89%
EBT Growth (3y)
-106.33%-142.26%-80.89%-41.65%-17.74%-31.84%1.33%-0.36%-10.64%-3.74%-1.31%-1.95%15.81%13.05%
EBT Growth (1y)
-94.81%-33.67%-42.87%2.24%-56.55%-50.93%-3.13%21.99%-6.27%4.73%30.70%-10.90%30.39%-5.82%-36.89%-22.49%19.34%34.79%
EBIT (QoQ)
30.78%-2.48%-57.41%8.22%-47.83%36.81%9.78%0.67%-86.92%45.51%25.29%-31.17%-16.48%5.97%6.68%-19.87%12.55%31.58%
EBIT Margin (QoQ)
0.95M0.01M0.19M0.23M-0.11M0.58M0.08M-0.04M-0.19M0.00M
EBIT Margin Growth (5y)
-0.31M-0.36M0.61M1.23M4.11M-0.37M0.93M
EBIT Margin Growth (3y)
-0.18M-0.35M-0.65M-0.30M0.37M
EBIT Margin Growth (1y)
1.03M3.95M-0.15M1.39M-0.22M0.51M0.43M-0.15M
EBIT Growth (5y)
-53.53%-57.06%-42.34%-22.55%-16.76%-5.90%7.13%
EBIT Growth (3y)
-116.94%-143.96%-81.35%-39.73%-21.07%-32.54%1.29%-1.26%-9.94%0.56%-0.24%-0.78%15.40%13.12%
EBIT Growth (1y)
-98.61%-33.30%-47.28%-2.48%-59.03%-49.35%-2.82%16.29%-5.84%8.72%24.42%0.19%37.80%-7.33%-34.07%-22.52%8.01%33.07%
EBITDA Margin (QoQ)
0.95M0.01M0.19M-0.11M0.58M0.08M-0.04M-0.19M0.00M
EBITDA Margin Growth (5y)
-0.31M-0.36M0.61M1.23M4.10M-0.37M0.94M
EBITDA Margin Growth (3y)
-0.18M-0.35M-0.65M0.37M
EBITDA Margin Growth (1y)
1.02M3.95M-0.15M-0.22M0.50M0.43M-0.15M
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-89.13%40.98%-19.06%21.00%-42.70%36.64%-60.50%-5.56%43.14%-10.62%-33.43%3.38%6.25%-2.36%1.01%34.89%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-38.39%-64.43%-45.52%-28.70%-10.97%-7.78%-6.81%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-77.60%-127.91%-73.84%-62.95%-8.47%-21.40%-40.47%5.90%-16.01%-3.88%2.32%8.42%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-216.95%12.90%-72.32%14.96%-14.64%-53.18%38.97%-6.55%11.42%18.92%-33.69%-23.71%8.22%38.15%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
65.45%29.49%44.52%-36.66%62.90%-3.92%-33.67%-100.00%-4,344,600.00%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
656.10%4,211.28%1,009.04%501.77%376.17%349.75%96.85%-57.61%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
23.73%72.53%27,026.26%43.27%-34.25%-100.00%-101.38%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-10.00%-6.89%-58.34%-23.95%-32.80%-18.10%5.54%-32.40%176.07%-9.78%59.16%-28.85%-13.81%-12.38%-26.37%31.45%136.59%-20.63%-20.79%-10.69%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
22.70%-18.71%-21.22%-22.17%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
16.33%-38.87%-26.79%-33.50%-34.45%-35.77%-22.34%-6.80%41.78%40.30%27.50%39.91%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
392.21%-26.30%-66.86%-73.45%-80.17%-82.56%-55.82%-60.73%61.32%77.70%167.98%182.03%-11.95%-14.48%-60.44%-26.91%100.63%81.75%95.52%32.84%
Capital Expenditures (QoQ)Capex (QoQ)
-65.45%-29.49%-67.01%-82.16%-97.08%94,400.00%
Capital Expenditures Growth (3y)Capex Growth (3y)
31.14%360.88%-22.86%-89.07%-96.85%-56.01%
Capital Expenditures Growth (1y)Capex Growth (1y)
-23.73%-72.53%41.15%-99.85%4,873.68%
Assets (QoQ)
-8.41%-3.56%-15.18%-11.18%-14.92%-11.52%-14.36%-22.80%32.00%-21.67%31.69%-25.16%-15.61%-4.12%-15.40%11.57%107.98%-17.88%-17.70%-14.20%
Assets Growth (5y)
18.90%-17.16%-19.41%-20.84%
Assets Growth (3y)
24.67%-32.80%-24.92%-30.37%-32.25%-32.38%-32.44%-27.10%-1.80%-4.21%-5.48%-2.09%
Assets Growth (1y)
305.91%-21.74%-29.68%-33.45%-38.18%-43.29%-42.74%-50.23%-22.78%-31.63%5.12%1.90%-34.85%-20.26%-48.77%-23.63%88.22%61.20%56.82%20.60%

Gain Therapeutics Growth Metrics API

Pull Gain Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GANX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY